Literature DB >> 2468295

Inhibitory function of VIP-PHI and galanin in canine pylorus.

H D Allescher1, E E Daniel, J Dent, J E Fox.   

Abstract

Contractions of canine pylorus and adjacent muscles were recorded with antral and duodenal strain gauges and a Dent sleeve manometric assembly with additional side holes in the pylorus. In vivo, vasoactive intestinal polypeptide (VIP) and peptide histamine isoleucine (PHI) given through the gastroepiploic artery inhibited both spontaneous and acetylcholine-induced pyloric contractions, before and after neural blockade with tetrodotoxin. Galanin inhibited only nerve-stimulated contractions. VIP greater than PHI much greater than galanin inhibited pyloric motor activity initiated by field stimulation of duodenal intramural nerves or intraduodenal infusion of 0.1 N HCl. In vitro, forskolin or field stimulation of nerves inhibited contractions of the pyloric muscle induced by various agonists but VIP-PHI failed to inhibit these contractions on two-thirds of the strips. The in vivo results suggest that VIP (or PHI) may be an inhibitory mediator in the pylorus acting directly on smooth muscle. Galanin may inhibit neural excitatory pathways in the pylorus. However, the structures on which VIP and PHI act in vivo may have become nonfunctional in vitro and other mediators account for the neural inhibition observed in isolated strips.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468295     DOI: 10.1152/ajpgi.1989.256.4.G789

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

Review 1.  Galanin.

Authors:  M E Vrontakis; A Torsello; H G Friesen
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

2.  Extrinsic primary afferent neurons projecting to the pylorus in the domestic pig--localization and neurochemical characteristics.

Authors:  Michal Zalecki
Journal:  J Mol Neurosci       Date:  2013-09-20       Impact factor: 3.444

3.  Role of NO in pyloric, antral, and duodenal motility and its interaction with other inhibitory mediators.

Authors:  H D Allescher; E E Daniel
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

4.  Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future?

Authors:  Brian E Lacy; Kirsten Weiser; Abigail Kennedy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-04

5.  Heterogenous distribution of peptide-containing nerve fibres within the circular muscle layer of the human pylorus.

Authors:  T Domoto; M Oki; T Kotoh; T Nakamura
Journal:  Clin Auton Res       Date:  1992-12       Impact factor: 4.435

6.  Contribution of ATP and nitric oxide to NANC inhibitory transmission in rat pyloric sphincter.

Authors:  P Soediono; G Burnstock
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.